NEUROGENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.35 USD | -1.40% |
|
+0.32% | +92.72% |
| Jun. 03 | Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program | MT |
| Jun. 03 | Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program | CI |
Chart calendar Neurogene Inc.
89f96.RIpXBW1ypNY_LiI5nDjiMVaOWue6kj2d9FbwRoqToxg.feUQcyoL4q5gcW588wuVQDrLEo7Nv2rSlQ-WcPv99ylw2zpCDyPdkFxARQ~e3248ae36ca43679034f22594eb9c3a1
Upcoming events on Neurogene Inc.
Past events on Neurogene Inc.
| 2024-05-10 07:30 am | Q1 2024 Earnings Release |
| 2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting - Poster No. 1408 |
| 2024-03-20 09:30 am | Stifel CNS Day |
| 2024-03-18 04:14 pm | Q4 2023 Earnings Release |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2023-07-18 08:30 am | Neoleukin Therapeutics, Inc. and Neurogene Inc. Merger Call |
| 2023-06-08 04:30 pm | Annual General Meeting |
| 2023-05-09 03:42 pm | Q1 2023 Earnings Release |
| 2022-12-12 12:45 pm | American Society of Hematology Meeting - Publication Number: 684 |
| 2022-11-14 04:03 pm | Q3 2022 Earnings Release |
| 2022-08-10 01:00 pm | Canaccord Growth Conference |
| 2022-08-09 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-09 04:02 pm | Interim 2022 Earnings Release |
| 2022-05-25 12:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 04:30 pm | Annual General Meeting |
| 2022-05-11 04:20 pm | Bank of America Healthcare Conference |
| 2022-05-09 04:05 pm | Q1 2022 Earnings Release |
| 2022-04-14 12:00 pm | Canaccord Horizons in Oncology Virtual Conference |
| 2022-04-13 10:00 am | American Association of Cancer Research Meeting - Abstract No 4227 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,6 -56,3 1.33% | -80,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -53,6 32.24% | -70,3 |
|
Net income Million USD | Released Forecast Spread | -55,2 | -36,3 -53,9 32.58% | -72,0 |
|
EPS USD | Released Forecast Spread | -10,6 | -7,80 -5,58 -39.84% | -4,12 |
| Announcement Date | 08/11/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -15,5 4.64% | -18,8 -15,3 -22.59% | -19,9 | -20,7 | -21,5 | -20,0 | -20,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,38 -14,9 116% | -16,9 -13,8 -22.52% | -17,3 | -17,8 | -18,3 | -18,7 | -19,2 |
|
Net income Million USD | Released Forecast Spread | 2,38 -15,1 115.75% | -16,9 -15,0 -13.04% | -17,5 | -18,4 | -19,2 | -18,7 | -19,2 |
|
EPS USD | Released Forecast Spread | -1,17 | -1,00 -0,95 -5.54% | -1,03 | -1,07 | -0,99 | -1,05 | -1,04 |
| Announcement Date | 18/03/24 | 10/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Neurogene Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NGNE Stock
- Calendar Neurogene Inc.
